Monthly Archives: October 2022

Tweet by Genentech Alzheimer’s prevention

Genentech ⁦‪@genentech‬⁩ This year we initiated an Alzheimer’s prevention study to examine the potential to slow the onset and progression of the disease in people with early signs of the disease. Learn more about our approach and the importance of intervening with the right medicine at the right time. 10/10/22, 9:31 AM Joseph Thornton

Laxatives infographic. Tweet by Paul Wischmeyer MD ⎪ #NutritionMatters 💪 on Twitter

Paul Wischmeyer MD ⎪ #NutritionMatters 💪 ⁦‪@Paul_Wischmeyer‬⁩ 💩How laxatives work #MedEd #MedTwitter #FOAMed Remember BOSS for the 4 classes 💡🧠 #GITwitter B: Bulk-forming O: Osmotic S: Stool softeners S: Stimulant pic.twitter.com/I5qKRbtkiG 10/14/22, 7:26 PM Joseph Thornton

Tweet by Daniel J Drucker on Twitter

Daniel J Drucker ⁦‪@DanielJDrucker‬⁩ The extent to which liraglutide, dulaglutide, semaglutide, and tirzepatide produce differential CNS penetration and GLP-1R target engagement has been partially studied in mice, but comparative human data using controlled PK & fMRI or PET is not available insight.jci.org/articles/view/… pic.twitter.com/v6RtslkD2s 10/13/22, 2:41 PM Joseph Thornton

Tweet by World Obesity on policy plan. T2dm and obesity

World Obesity ⁦‪@WorldObesity‬⁩ With obesity & diabetes targets catastrophically off-track, we urgently need a system-wide approach if we are to halt the rise of diet-related NCDs. Our new #PolicyBrief with ⁦‪@IntDiabetesFed‬⁩ explores joint action to address obesity & diabetes. ➡️ worldobesity.org/news/idf-and-w… pic.twitter.com/rzIZq6p1WZ 10/14/22, 4:01 AM Joseph Thornton

Tweet by Genentech preventing Alzheimer’s

Genentech ⁦‪@genentech‬⁩ This year we initiated an Alzheimer’s prevention study to examine the potential to slow the onset and progression of the disease in people with early signs of the disease. Learn more about our approach and the importance of intervening with the right medicine at the right time. 10/10/22, 9:31 AM Joseph Thornton